Symposium Program/Agenda

The times in the tables below are USA Eastern Time.  The following is provided to help you convert it into your location time.

Paris, France: +6 hours

New Delhi, India: +10.5 hours

Beijing, China: +13 hours

Seoul, Korea: + 14 hours

Click here for a time conversion tool.

Due to the generosity of our sponsors, this is a free event.
Schedule updated: December 1, 2020, 10:59 PM CT, Chicago, IL

Saturday, December 5, 2020

Sunday, December 6, 2020

Start-End (USA ET)
Session TitlePresenters
6:00 AM – 7:00 AMPoster session: Attendees will go on their own to view and chat with presenters on the iPosters website.N/A
7:00 AM – 7:30 AMVirtual Waiting Room Opens
N/A
7:30 AM – 7:40 AMWelcome Message from ChairsDavinder Parsad, MD & Iltefat Hamzavi, MD
VIS 2020 Co-Chairs
7:40 AM – 8:00 AMGenetic and Environmental Correlates of VitiligoInvited Speaker:
Richard A. Spritz, MD
8:00 AM – 8:10 AM
Prevalence of Psychosocial Comorbidities in Vitiligo: A Systematic Literature ReviewKhaled Ezzedine, MD, PhD
8:10 AM – 8:20 AMComparative Study of Safety and Efficacy of Oral Betamethasone Pulse Therapy and Azathioprine in VitiligoMahajabeen Saheb Patel Madarkar, MD
8:20 AM – 8:30 AMEffects of Adding PRP to Microneedling Plus 5-Fluorouracil Therapy in Acral Vitiligo: A Split-Body Randomized TrialPankhuri Dudani, MBBS
8:30 AM – 8:50 AMVitiligo and Comorbidity: A Comprehensive ReviewInvited Speaker:
Jung Me Bae, MD, PhD
8:50 AM – 9:00 AMAutologous Non-cultured, Non-trypsinized Melanocyte-Keratinocyte Graft Homogenized in Plasma Gel Followed by Narrow-Band Ultraviolet B Therapy for Stable Vitiligo: A Novel TechniqueLamia Elgarhy, MD
9:00 AM – 9:10 AMDonor to Recipient Ratios in the Surgical Treatment of Vitiligo and Piebaldism: A Systematic ReviewVidhya Shankar Narayan, MD
9:10 AM – 9:20 AMPatient Stories, Data and Demo – MyVitiligoTeam
(Patient Social Network)
Eric Peacock, Co-Founder and CEO
9:20 AM – 9:40 AMPoster Q&A Sessions #1Bibeau
EL-Hawary
Han
Lee
Narayan
Picardo
Ragab
9:40 AM – 10:00 AMAdvances in Immune Mechanisms of VitiligoInvited Speaker:
John E. Harris, MD, PhD
10:00 AM – 10:10 AMEffects of Ruxolitinib Cream on Affected Body Areas in Patients with Vitiligo: Subgroup Analysis from a 52-Week, Randomized, Double-Blind TrialPearl Grimes, MD
10:10 AM – 10: 20 AMInfluencing Factors on the Patient Global Assessment Score for Vitiligo SeverityNanja van Geel, MD, PhD
10:20 AM – 10:30 AMPilot Network Model for Automated Vitiligo Lesion Segmentation: Promise and ChallengesJesslyn Alyce Magee, MS
10:30 AM – 10:50 AMVitiligo: Looking at the Memory T Cell ResponseInvited Speaker:
Julien Seneschal, MD, PhD
10:50 AM – 11:10 AMPoster Q&A Sessions #2Castro Porto Silva Lopes
Deshpande
Gandhi
Karthik
Krishnappa
11:10 AM – 11:20 AMWrap up and summary of dayDavinder Parsad, MD & Iltefat Hamzavi, MD
VIS 2020 Co-Chairs
11:20 AM – 1:00 PMPoster session: Attendees will go on their own to view and chat with presenters on the iPosters website.N/A
Start (USA ET)
Session TitlePresenters
6:00 AM – 7:00 AMPoster session: Attendees will go on their own to view and chat with presenters on the iPosters website.
N/A
7:00 AM – 7:30 AMVirtual Waiting Room Opens
N/A
7:30 AM – 7:40 AMWelcome Back Message from ChairsDavinder Parsad, MD & Iltefat Hamzavi, MD
2020 VIS Co-Chairs
7:40 AM – 8:00 AMInternational Collaborative Project to Standardize the Assessment and Monitoring of Vitiligo in Clinical Trials, Registries and Clinical PracticeInvited Speaker:
Nanja van Geel, MD, PhD
8:00 AM – 8:10 AM
Analysis of 24-Week Response to Ruxolitinib Cream for the Treatment of Vitiligo Based on Patient Demographics and Clinical CharacteristicsIltefat H. Hamzavi, MD, FAAD
8:10 AM – 8:20 AMAn Open-Label Pilot Study of Abatacept (CTLA4-Ig) for the Treatment of Nonsegmental VitiligoVictor Huang, MD
8:20 AM – 8:30 AMAnalysis of Matched Skin and Gut Microbiome of Vitiligo Patients Reveals Dysbiosis in Lesional Skin: Association with Mitochondrial Damage and Changes in Immune FunctionMeri K. Tulic, PhD
8:30 AM- 8:50 AMAdvances in Treatment of Vitiligo With Jak InhibitorsInvited Speaker:
Amit G. Pandya, MD
8:50 AM – 9:00 AMRisk Factors of Infection Post Non-cultured Melanocyte Keratinocyte Transplantation for VitiligoSaad Altalhb, MBBS
9:00 AM – 9:10 AMSurvey Investigating the Prevalence of Vitiligo and Vitiligo Signs among Adults in Europe, Japan, and the United StatesJohn E. Harris, MD, PhD
9:10 AM – 9:20 AMAn Identification of Potential Therapeutics for Vitiligo by Mass Screening for 1,732 Medicines in Korean National Health Insurance DatabaseJung Me Bae, MD, PhD
9:20 AM- 9:40 AMPoster Q&A Sessions #3Abdallah
Bae
Ghia
Ju
Yeon
Goyal
Mogawer
9:40 AM – 10:00 AMRecent Advances in the Surgical Management of VitiligoInvited Speaker:
Davinder Parsad, MD
10:00 AM – 10:10 AMA Comparative Pilot Study of Dipstick versus Open-Spray Cryotherapy Techniques as Depigmentation Treatments for VitiligoHaitham M. Saleh, Msc
10:10 AM – 10:20 AMTherapeutic Response Biomarkers for Vitiligo Patients on Narrow Band Uvb and Topical Tacrolimus Combination TherapyYouwen Zhou, MD, PhD
10:20 AM – 10:30 AMVitiligo and Psychological Comorbidities: A Retrospective Analysis in an Urban PopulationSimone Nichole Boeckmann Montgomery, BA
10:30 AM – 10:50 AMPhototherapy for Vitiligo: How to Optimize and What the Future HoldsInvited Speaker:
Iltefat H. Hamzavi, MD
10:50 AM – 11:10 AMPoster Q&A Sessions #4Bhattacharya
El-Samanoudy
Mareddy
Nassar
Saatov
Sany
11:10 AM – 11:20 AMWrap up and summary of dayDavinder Parsad, MD & Iltefat Hamzavi, MD
2020 VIS Co-Chairs
11:20 AM – 1:00 PMPoster session: Attendees will go on their own to view and chat with presenters on the iPosters website.N/A